Correlation Between ZyVersa Therapeutics and Scisparc
Can any of the company-specific risk be diversified away by investing in both ZyVersa Therapeutics and Scisparc at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ZyVersa Therapeutics and Scisparc into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ZyVersa Therapeutics and Scisparc, you can compare the effects of market volatilities on ZyVersa Therapeutics and Scisparc and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ZyVersa Therapeutics with a short position of Scisparc. Check out your portfolio center. Please also check ongoing floating volatility patterns of ZyVersa Therapeutics and Scisparc.
Diversification Opportunities for ZyVersa Therapeutics and Scisparc
0.57 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between ZyVersa and Scisparc is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding ZyVersa Therapeutics and Scisparc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Scisparc and ZyVersa Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ZyVersa Therapeutics are associated (or correlated) with Scisparc. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Scisparc has no effect on the direction of ZyVersa Therapeutics i.e., ZyVersa Therapeutics and Scisparc go up and down completely randomly.
Pair Corralation between ZyVersa Therapeutics and Scisparc
Given the investment horizon of 90 days ZyVersa Therapeutics is expected to under-perform the Scisparc. In addition to that, ZyVersa Therapeutics is 1.99 times more volatile than Scisparc. It trades about -0.16 of its total potential returns per unit of risk. Scisparc is currently generating about 0.06 per unit of volatility. If you would invest 23.00 in Scisparc on August 28, 2024 and sell it today you would earn a total of 1.00 from holding Scisparc or generate 4.35% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
ZyVersa Therapeutics vs. Scisparc
Performance |
| Timeline |
| ZyVersa Therapeutics |
| Scisparc |
ZyVersa Therapeutics and Scisparc Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with ZyVersa Therapeutics and Scisparc
The main advantage of trading using opposite ZyVersa Therapeutics and Scisparc positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ZyVersa Therapeutics position performs unexpectedly, Scisparc can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Scisparc will offset losses from the drop in Scisparc's long position.| ZyVersa Therapeutics vs. Cns Pharmaceuticals | ZyVersa Therapeutics vs. Immix Biopharma | ZyVersa Therapeutics vs. Hepion Pharmaceuticals | ZyVersa Therapeutics vs. Zura Bio Limited |
| Scisparc vs. Virax Biolabs Group | Scisparc vs. ZyVersa Therapeutics | Scisparc vs. Unicycive Therapeutics | Scisparc vs. Quoin Pharmaceuticals Ltd |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |